X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (484) 484
Conference Proceeding (44) 44
Publication (26) 26
Dissertation (22) 22
Patent (15) 15
Reference (3) 3
Book Chapter (2) 2
Book / eBook (1) 1
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (224) 224
female (187) 187
male (172) 172
middle aged (157) 157
aged (144) 144
adult (126) 126
index medicus (116) 116
oncology (113) 113
aged, 80 and over (75) 75
lung neoplasms - drug therapy (69) 69
carcinoma, non-small-cell lung - drug therapy (57) 57
lung neoplasms - pathology (56) 56
respiratory system (56) 56
chemotherapy (53) 53
analysis (52) 52
lung cancer (50) 50
cancer (48) 48
retrospective studies (48) 48
risk factors (44) 44
computer science, interdisciplinary applications (43) 43
treatment outcome (41) 41
knowledge management (39) 39
gefitinib (36) 36
lung neoplasms - genetics (36) 36
lung neoplasms - mortality (36) 36
operations research & management science (36) 36
computer science, artificial intelligence (35) 35
non-small cell lung cancer (34) 34
taiwan (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
neoplasm staging (31) 31
research (31) 31
adenocarcinoma (30) 30
carcinoma, non-small-cell lung - pathology (30) 30
cisplatin (30) 30
engineering, manufacturing (29) 29
case-control studies (28) 28
care and treatment (27) 27
lung cancer, non-small cell (27) 27
smoking (27) 27
carcinoma, non-small-cell lung - mortality (26) 26
prognosis (26) 26
survival rate (26) 26
adenocarcinoma - genetics (25) 25
management (25) 25
adenocarcinoma - drug therapy (24) 24
epidermal growth factor receptor (24) 24
studies (24) 24
adenocarcinoma - pathology (23) 23
taiwan - epidemiology (23) 23
engineering, electrical & electronic (22) 22
health aspects (22) 22
medicine, general & internal (22) 22
survival (22) 22
survival analysis (22) 22
antineoplastic agents - therapeutic use (21) 21
docetaxel (21) 21
non-small-cell lung cancer (21) 21
salvage therapy (21) 21
erlotinib (20) 20
follow-up studies (20) 20
internal medicine (20) 20
polymorphism, single nucleotide (20) 20
gemcitabine (19) 19
hematology, oncology and palliative medicine (19) 19
mutation (19) 19
carcinoma (18) 18
medical colleges (18) 18
medicine (18) 18
methods (18) 18
ontology (18) 18
trial (18) 18
adolescent (17) 17
genetic predisposition to disease (17) 17
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
concurrent engineering (16) 16
deoxycytidine - analogs & derivatives (16) 16
surgery (16) 16
vinorelbine (16) 16
virtual enterprise (16) 16
algorithms (15) 15
biochemistry & molecular biology (15) 15
data mining (15) 15
genotype (15) 15
orthopedics (15) 15
pulmonary/respiratory (15) 15
risk (15) 15
adenocarcinoma - mortality (14) 14
adenocarcinoma of lung (14) 14
basic electric elements (14) 14
carboplatin (14) 14
cell lung-cancer (14) 14
cisplatin - administration & dosage (14) 14
disease-free survival (14) 14
electric solid state devices not otherwise provided for (14) 14
electricity (14) 14
oncology, experimental (14) 14
paclitaxel (14) 14
quinazolines - therapeutic use (14) 14
semiconductor devices (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Nursing, ISSN 0962-1067, 2010, Volume 19, Issue 3-4, pp. 432 - 439
Aims. This study explored barriers that older residents of long-term care (LTC) institutions experience in regular physical activity participation. Background.... 
Physical activity | Nursing home | Older adults | Barriers | Long-term care | NURSING | long-term care | nursing home | AMERICANS | MODEL | physical activity | WOMEN | EXPERIENCES | barriers | older adults | EXERCISE BEHAVIOR | BELIEFS | PEOPLE | HEALTH | BENEFITS | LIFE | Fear | Life Style | Nursing Homes | Exercise | Humans | Taiwan | Aged | Long-Term Care | Physical fitness | Analysis | Long-term care of the sick | Exercise for the aged | Physical fitness for the aged
Journal Article
Computers in Industry, ISSN 0166-3615, 09/2014, Volume 65, Issue 7, p. 1085
  Knowledge, as the most important resource for the knowledge economy in the 21st century, is fundamental to enterprise competitive strength. Therefore, how to... 
Studies | Success factors | Ontology | Data collection | Knowledge management
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 528 - 538
Journal Article
Journal Article
Online Information Review, ISSN 1468-4527, 11/2016, Volume 40, Issue 7, pp. 913 - 937
Purpose For an enterprise, it is essential to win as many customers as possible. The key to successfully winning customers is often determined by understanding... 
Journal Article
International Journal of Nursing Practice, ISSN 1322-7114, 06/2016, Volume 22, Issue 3, pp. 239 - 246
Journal Article
Journal of Nursing Scholarship, ISSN 1527-6546, 05/2015, Volume 47, Issue 3, pp. 211 - 218
Journal Article
Knowledge-Based Systems, ISSN 0950-7051, 09/2012, Volume 33, pp. 1 - 28
Capable of providing an interactive platform for enterprise experts to create and share empirical knowledge cooperatively, professional virtual communities... 
Design engineering | Construction | Communities | Evolution | Knowledge management | Extraction | Internet | Empirical analysis
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 777 - 786
Summary Background The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly... 
Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | CARBOPLATIN-PACLITAXEL | 1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | THERAPY | NSCLC | ONCOLOGY | ADENOCARCINOMA | OPEN-LABEL | EGFR | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Administration, Intravenous | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Online Information Review, ISSN 1468-4527, 01/2016, Volume 40, Issue 1, pp. 146 - 167
Purpose - Customer acquisition and retention methods are the most critical issues for any enterprise. By identifying potential customers and targeting them... 
Consumption | Communities | Searching | Markets | Mathematical models | Virtual organization | Foods | Marketing
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article